Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UPDATED: Clear 'Yes' From Shareholders On Takeda/Shire Deal

Executive Summary

Dec. 5, 2018 was a big day in the timeline of Takeda's proposed acquisition of Shire, with shareholder votes being held at both companies. The deal passed the first of its final hurdles, easily receiving approval at an EGM of Takeda shareholders, followed by a similar positive vote of confidence from Shire investors.


Related Content

Finance Watch: Relay Raises $400m – And It's Only The Third-Largest Biopharma VC Round Of 2018
Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain
Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts